# Diabetes Research Hub — Iteration Run Report
**Date:** 2026-06-12 (Friday)
**Agent:** diabetes-research-iterate (autonomous scheduled run)

## Summary
Processed the priority work queue: ran the per-run credibility sweep, validated 5 previously-unvalidated research paths against external evidence, and rebuilt the full quality pipeline (41/41 stages [OK]). Git push remains blocked from the sandbox and requires user action.

## Step 0 — State Load
- Loaded `Analysis/Results/agent_state.json` (v1).
- Corpus status: **285 papers, all VETTED** (272 VETTED / 13 FLAGGED as legitimate off-topic exclusions). No vetting backlog.
- Research paths: 57 tracked; `validated_paths` 51 entering this run.
- Work queue: 21 items; top item is the user-action git-push blocker.

## Step 4 — Credibility Sweep (every run) — CLEAN
- No fabricated PMIDs (>42,000,000) in any `.py` script or in the key data JSONs (`research_paths.json`, `validated_research_paths.json`, `gap_evidence.json`, `pmid_verification.json`).
- No "zero SAEs" / "zero rejection" / overstated-preclinical ("curative") claims. The `zero SAEs/rejection` string hits inside `agent_state.json` are **run-history meta-notes describing prior sweeps**, not scientific claims — verified by walking the JSON structure.

## Path Validation (queue item, priority 4) — 5 paths validated
| Path | Rating | Key external evidence |
|------|--------|----------------------|
| oxidative_stress → T2D | **VALIDATED** | Banik 2021 SR/MA (PMID 34622023): 22 case-control studies, 2,853 subjects; MDA & NO elevated, glutathione/TAS reduced in T2D. *Caveat: antioxidant-supplementation RCTs have failed → association robust, therapeutic causality unproven.* |
| empagliflozin → T2D | **VALIDATED** | Phase III RCTs: add-on metformin HbA1c −0.70/−0.77% vs −0.13% placebo (PMID 24722494); add-on pioglitazone (PMID 23906415); 78-wk add-on basal insulin (PMID 26040302). |
| oxidative_stress → nephropathy | **VALIDATED** | Consensus reviews (PMID 26906673, 21557044): excess ROS via polyol/PKC/AGE-RAGE/hexosamine + NADPH oxidases central to DKD initiation/progression. |
| tacrolimus → inflammation | **PARTIALLY_VALIDATED** | Bidirectional: CNI reduces NFAT-driven IL-2/T-cell cytokines, but in macrophages calcineurin blockade raises pro-inflammatory cytokines, and CNIs induce TLR4-mediated vascular inflammation (Nature Sci Rep srep27915; StatPearls NBK558995). No fabricated PMID recorded for these sources. |
| hydroxychloroquine → inflammation | **VALIDATED** | RCT (PMID 36777472): 12-wk HCQ add-on in uncontrolled T2D lowered IL-6 & hsCRP, raised adiponectin, with parallel beta-cell/insulin-resistance and HbA1c/FPG/PPG improvement. |

`validated_paths`: **51 → 56.**

### Remaining unvalidated paths (queued for next runs)
oxidative_stress → autoimmune; belatacept → T1D; rapamycin → nephropathy; teplizumab → autoimmune; insulin_glargine → T2D.

## Step 5 — Pipeline Rebuild
`run_quality_improvements.py` — **all 41 stages [OK].**

## Step 6 — State & Git
- `agent_state.json` updated: new `run_history` entry (now 60 runs), `validated_paths` (56), path-validation queue item refreshed, git-blocker note appended.
- **Git: BLOCKED.** `git commit` fails — `.git/index.lock` is recreated (Operation not permitted, OneDrive-synced) and `.git/objects` tmp writes are denied. Branch ~37 commits ahead of `origin/main`.
- **All 2026-06-12 changes are saved to working files on disk** and persist for the next run regardless of git state.

### Required user action
From local PowerShell at `C:\Users\justi\OneDrive\Diabetes_Research`:
```
Remove-Item .git\index.lock -ErrorAction SilentlyContinue
Remove-Item .git\HEAD.lock  -ErrorAction SilentlyContinue
git add -A
git commit -m "Daily iterations through 2026-06-12"
git push origin main
```

## Notes
- Today is Friday → weekly new-paper PubMed sweep (Monday-only) was correctly skipped.
- No gap audits were due (all scheduled late June / July).
- This is research synthesis, not medical advice.
